QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 TableSense: Spreadsheet Table Detection with Convolutional Neural Networks 会议论文 THIRTY-THIRD AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE / THIRTY-FIRST INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE / NINTH AAAI SYMPOSIUM ON EDUCATIONAL ADVANCES IN ARTIFICIAL INTELLIGENCE, 2019-01-01 作者:  Dong, Haoyu;  Liu, Shijie;  Han, Shi;  Fu, Zhouyu;  Zhang, Dongmei 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/30 Evolution of Kelvin-Helmholtz instability at Venus in the presence of the parallel magnetic field 会议论文 2014 XXXITH URSI GENERAL ASSEMBLY AND SCIENTIFIC SYMPOSIUM (URSI GASS), 2014-01-01 作者:  Lu, Haoyu;  Cao, Jinbin;  Zhang, Tielong;  Fu, Huishan 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/06 Fabrication of multi-compartmental microparticles with tailored spatial configuration for co-delivery of multiple drugs 会议论文 Suzhou, PEOPLES R CHINA, SEP 23-26, 2016 作者:  Chen, Qiulan[1,2];  Xie, Weiguang[4];  Jin, Haoyu[1];  Zhang, Weihong[3];  Fu, Yu[2] 收藏  |  浏览/下载：0/0  |  提交时间：2019/12/13 DCZ3112, a novel Hsp90 inhibitor, exerts potent antitumor activity against HER2-positive breast cancer through disruption of Hsp9O-Cdc37 interaction 会议论文 CANCER LETTERS, 70-80, 2018 作者:  Chen, Xiangling;  Liu, Peng;  Wang, Quanren;  Li, Yun;  Fu, Li 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/25 Cdc37  DCZ3112  Geldanamycin  Hsp90  HER2-positive  breast  cancer   Pharmacologic characterization of CT-711, a novel dual inhibitor of ALK and c-Met 会议论文 AMERICAN JOURNAL OF CANCER RESEARCH, 1541-1550, 2018 作者:  Wang, Lei;  Gao, Mingzhao;  Tong, Mengya;  Xie, Chengying;  He, Ye 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/25 CT-711  ALK  c-Met  crizotinib  antitumor  activity  pharmacokinetics